C21 Investments Inc (CXXIF)
0.2385
+0.02
(+8.41%)
USD |
OTCM |
Sep 19, 16:00
C21 Investments Price to Book Value: 0.9248 for Sept. 19, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 19, 2024 | 0.9248 |
| September 18, 2024 | 0.853 |
| September 17, 2024 | 0.9112 |
| September 16, 2024 | 0.9306 |
| September 13, 2024 | 0.929 |
| September 12, 2024 | 0.853 |
| September 11, 2024 | 0.9694 |
| September 10, 2024 | 0.9771 |
| September 09, 2024 | 0.9771 |
| September 06, 2024 | 0.8724 |
| September 05, 2024 | 0.9597 |
| September 04, 2024 | 0.9655 |
| September 03, 2024 | 0.9306 |
| August 30, 2024 | 0.8872 |
| August 29, 2024 | 0.8724 |
| August 28, 2024 | 0.8918 |
| August 27, 2024 | 0.834 |
| August 26, 2024 | 0.9054 |
| August 23, 2024 | 0.9571 |
| August 22, 2024 | 0.8918 |
| August 21, 2024 | 0.9151 |
| August 20, 2024 | 0.9345 |
| August 19, 2024 | 1.062 |
| August 16, 2024 | 1.008 |
| August 15, 2024 | 0.9073 |
| Date | Value |
|---|---|
| August 14, 2024 | 1.047 |
| August 13, 2024 | 0.9021 |
| August 12, 2024 | 0.8724 |
| August 09, 2024 | 0.9364 |
| August 08, 2024 | 1.003 |
| August 07, 2024 | 0.9694 |
| August 06, 2024 | 1.057 |
| August 05, 2024 | 0.9694 |
| August 02, 2024 | 0.9539 |
| August 01, 2024 | 1.076 |
| July 31, 2024 | 1.090 |
| July 30, 2024 | 1.221 |
| July 29, 2024 | 1.082 |
| July 26, 2024 | 1.016 |
| July 25, 2024 | 0.9694 |
| July 24, 2024 | 0.9694 |
| July 23, 2024 | 1.072 |
| July 22, 2024 | 1.008 |
| July 19, 2024 | 0.9318 |
| July 18, 2024 | 1.047 |
| July 17, 2024 | 1.047 |
| July 16, 2024 | 1.041 |
| July 15, 2024 | 0.9694 |
| July 12, 2024 | 0.9635 |
| July 11, 2024 | 0.971 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5993
Minimum
Sep 30 2022
9.954
Maximum
Jan 07 2021
2.196
Average
1.424
Median
May 23 2022
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.4731 |
| Aurinia Pharmaceuticals Inc | 2.820 |
| Edesa Biotech Inc | 4.927 |
| Lexaria Bioscience Corp | 4.920 |
| Xenon Pharmaceuticals Inc | 3.673 |
Price to Book Value Related Metrics
| PS Ratio | 1.059 |
| PEG Ratio | -0.0036 |
| Price to Free Cash Flow | 22.89 |
| Price | 0.2385 |
| Earnings Yield | -15.35% |
| Market Cap | 28.63M |
| PEGY Ratio | -0.0036 |
| Operating PE Ratio | 375.07 |